会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • SUBSTITUTED XANTHINE DERIVATIVES
    • 取代的XANTHINE衍生物
    • US20140121226A1
    • 2014-05-01
    • US13949888
    • 2013-07-24
    • Roger D. TungJulie F. LiuScott L. Harbeson
    • Roger D. TungJulie F. LiuScott L. Harbeson
    • C07D473/04
    • C07D473/10C07B2200/05C07B2200/07C07D473/04
    • This invention relates to novel deuterated compounds that are substituted xanthine derivatives and pharmaceutically acceptable salts thereof. In particular, this invention relates to novel substituted xanthine derivatives that are deuterated derivatives of a pentoxifylline metabolite. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed deuterated compounds and compositions in methods of treating diseases and conditions for which pentoxifylline and related compounds are beneficial. The compounds of the invention are represented by the following structural formula: wherein the values of R1, R2, R3, R4, R5, Y1 and Y2 are described herein.
    • 本发明涉及新的氘代化合物,其是取代的黄嘌呤衍生物及其药学上可接受的盐。 特别地,本发明涉及作为己酮可可碱代谢物的氘代衍生物的新的取代黄嘌呤衍生物。 本发明还提供包含一种或多种本发明化合物和载体的组合物,以及所公开的氘代化合物和组合物在治疗己酮可可碱和相关化合物有益的疾病和病症的方法中的用途。 本发明的化合物由以下结构式表示:其中本文描述了R1,R2,R3,R4,R5,Y1和Y2的数值。